NASDAQ: CLLS
Cellectis Sa Stock Forecast, Predictions & Price Target

Analyst price target for CLLS

Based on 2 analysts offering 12 month price targets for Cellectis Sa

Min Forecast
$8.00+128.57%
Avg Forecast
$8.50+142.86%
Max Forecast
$9.00+157.14%

Should I buy or sell CLLS stock?

Based on 2 analysts offering ratings for Cellectis Sa.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CLLS stock forecasts and price targets.

CLLS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-14
lockedlocked$00.00+00.00%2025-12-23

1 of 1

CLLS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CLLS$3.52$8.50+141.48%Strong Buy
AVXL$2.71$22.00+711.81%Strong Buy
EDIT$2.67$6.00+124.72%Strong Buy
NERV$5.30$10.50+98.11%Buy
CGEN$2.61$5.00+91.57%Strong Buy

Cellectis Sa Stock Forecast FAQ

Is Cellectis Sa Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CLLS) stock is to Strong Buy CLLS stock.

Out of 2 analysts, 1 (50%) are recommending CLLS as a Strong Buy, 1 (50%) are recommending CLLS as a Buy, 0 (0%) are recommending CLLS as a Hold, 0 (0%) are recommending CLLS as a Sell, and 0 (0%) are recommending CLLS as a Strong Sell.

If you're new to stock investing, here's how to buy Cellectis Sa stock.

What is CLLS's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CLLS price target, the average CLLS price target is $8.50, with the highest CLLS stock price forecast at $9.00 and the lowest CLLS stock price forecast at $8.00.

On average, Wall Street analysts predict that Cellectis Sa's share price could reach $8.50 by Apr 14, 2027. The average Cellectis Sa stock price prediction forecasts a potential upside of 141.48% from the current CLLS share price of $3.52.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.